Today, we talk about a
collaborative project
which helps with
early drug discovery
by detecting and targeting
exactly which cells in the body
need treatment.
How is this all possible?
I'm Stephanie Essin, you'll
find out in this IDZ Weekly.
[MUSIC PLAYING]
Imagine putting a
microscope against your arm
and being able to see a whole
new world of cells and cell
cultures that you
never knew existed.
It kind of sounds
like The Lorax,
but I promise this isn't
based off a Dr. Seuss book,
and unfortunately there
are no talking animals.
Intel developers
have collaborated
with Novartis
Pharmaceuticals to accelerate
the speed of high
content screenings
of deep neural networks, from
11 hours to just 31 minutes.
This means that
scientists can now
look at an entire universe
of cell cultures at 20 times
the original rate.
This is so
significant because it
can be a key element in
early drug discovery.
Building off that, this type
of high content screening
allows a person to
analyze microscopic images
and study the
effects of thousands
of genetic, or
chemical treatments
on these various cell cultures.
The promise of
this new innovation
is that relevant
image features, which
can distinguish one
treatment from another,
will be automatically learned
from the data provided.
If you want to dive deeper
into this exciting topic,
check out the article
in the provided links.
You might not discover
an entirely new world,
but who knows?
Maybe that's right
around the corner.
Thanks for watching IDZ Weekly.
See you next Monday.
[MUSIC PLAYING]
